Preventing Microalbuminuria in Type 2 Diabetes

clinical trial

MedicalStudy clinical_trial Q61980191

Press Enter · cited answer in seconds

Summary

Preventing Microalbuminuria in Type 2 Diabetes is a clinical trial^[1].

Key Facts

Preventing Microalbuminuria in Type 2 Diabetes is in the country of Italy^[2].
Preventing Microalbuminuria in Type 2 Diabetes's instance of is recorded as clinical trial^[3].
Preventing Microalbuminuria in Type 2 Diabetes's start time is recorded as +2007-05-31T00:00:00Z^[4].
Preventing Microalbuminuria in Type 2 Diabetes's end time is recorded as +2016-07-31T00:00:00Z^[5].
Preventing Microalbuminuria in Type 2 Diabetes's sponsor is recorded as Mario Negri Institute for Pharmacological Research^[6].
Preventing Microalbuminuria in Type 2 Diabetes's main subject is recorded as diabetes^[7].
Preventing Microalbuminuria in Type 2 Diabetes's number of participants is recorded as {'unit': '1', 'amount': '+613'}^[8].
Preventing Microalbuminuria in Type 2 Diabetes's title is recorded as A Prospective, Randomized, Probe Trial to Evaluate Whether, at Comparable Blood Pressure Control, Combined Therapy With the ACEI Benazepril and the ARB Valsartan, Reduces the Incidence of Microalbuminuria More Effectively Than BEN or VAL Alone in Hypertensive Patients With Type 2 Diabetes and High-normal Albuminuria^[9].
Preventing Microalbuminuria in Type 2 Diabetes's short name is recorded as VARIETY^[10].
Preventing Microalbuminuria in Type 2 Diabetes's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}^[11].
Preventing Microalbuminuria in Type 2 Diabetes's ClinicalTrials.gov ID is recorded as NCT00503152^[12].
Preventing Microalbuminuria in Type 2 Diabetes's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[13].
Preventing Microalbuminuria in Type 2 Diabetes's research intervention is recorded as Valsartan/hydrochlorothiazide^[14].
Preventing Microalbuminuria in Type 2 Diabetes's research intervention is recorded as benazepril^[15].
Preventing Microalbuminuria in Type 2 Diabetes's clinical trial phase is recorded as phase III clinical trial^[16].
Preventing Microalbuminuria in Type 2 Diabetes's research subject recruitment status is recorded as completed^[17].
Preventing Microalbuminuria in Type 2 Diabetes's study type is recorded as interventional study^[18].

⭐ Popularity Graph

0/100 long tail

⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

Number of participantsP1132

612 (ACTUAL) 2026-09-26 Wikidata lists 613 ClinicalTrials.gov (US Government Public Domain)

End timeP582

2016-09 2026-09-26 Wikidata lists 2016-07-31 ClinicalTrials.gov (US Government Public Domain)

ClinicalTrials.gov (data processed by ClinicalTrials.gov on 2026-09-26); U.S. federal government data, public domain; lake licence_code custom-review

Quick Facts

Instance of clinical trial

Country Italy

Short name VARIETY

Properties

Clinical trial phase phase III clinical trial

End time July 31, 2016

Imported from wholeness_audit_2026-05-02

Main subject diabetes

Maximum age 80 year

Minimum age 40 year

Number of participants 613

Research intervention Valsartan/hydrochlorothiazide, benazepril

Research subject recruitment status completed

Sponsor Mario Negri Institute for Pharmacological Research

Start time May 31, 2007

Study type interventional study

Title A Prospective, Randomized, Probe Trial to Evaluate Whether, at Comparable Blood Pressure Control, Combined Therapy With the ACEI Benazepril and the ARB Valsartan, Reduces the Incidence of Microalbuminuria More Effectively Than BEN or VAL Alone in Hypertensive Patients With Type 2 Diabetes and High-normal Albuminuria

External References (1)

Clinicaltrials.gov id NCT00503152

🏷️ Also known as

en Preventing Microalbuminuria in Type 2 Diabetes

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

Class ancestry

[1] ↑ Preventing Microalbuminuria in Type 2 Diabetes is an instance of clinical trial (Q30612) [P31, primary]. Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA

4ort.xyz Knowledge Graph. (2026). Preventing Microalbuminuria in Type 2 Diabetes. Retrieved May 3, 2026, from https://4ort.xyz/entity/preventing-microalbuminuria-in-type-2-diabetes

MLA

“Preventing Microalbuminuria in Type 2 Diabetes.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/preventing-microalbuminuria-in-type-2-diabetes.

BibTeX

@misc{4ortxyz_preventing-microalbuminuria-in-type-2-diabetes_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Preventing Microalbuminuria in Type 2 Diabetes}}, year = {2026}, url = {https://4ort.xyz/entity/preventing-microalbuminuria-in-type-2-diabetes}, note = {Accessed: 2026-05-03}}

LLM prompt

According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Preventing Microalbuminuria in Type 2 Diabetes — https://4ort.xyz/entity/preventing-microalbuminuria-in-type-2-diabetes (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/preventing-microalbuminuria-in-type-2-diabetes · Last refreshed: May 3, 2026